Jun
2026
Shanghai New International Expo Center
Visit us
stand E3C06, Finished Dosage

Jiangsu Aidea Pharmaceutical Group Co., Ltd.

  • Country/Region:
    China
  • On CPHI since:
    2022
  • Certificates:
    1
  • Employees:
    500 - 999
Company types
Distributor/Import Export
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
Pharmaceutical Company (innovator finished products)
Contact info
  • No. 69, Xin Ganquan West Road, Hanjiang District, 225008, Yangzhou, China
Event information
CPHI & PMEC China 2026
  • 16 Jun 2026 - 18 Jun 2026
  • Shanghai New International Expo Center
  • Visit us at stand E3C06, Finished Dosage

Products Featured at CPHI & PMEC China 2026

  • Ainuovirine Tablets

    Product Ainuovirine Tablets

    The first innovative Class I anti-HIV/AIDS tablets approved for marketing in China. A new generation of non-nucleoside reverse transcriptase inhibitors (NNRTIs).
  • Ulinastatin

    Product Ulinastatin

    1、A natural broad-spectrum proteinase inhibitor extracted from human urine

    2、Block the process of SIRS and MODS

    2、Protect the function of vital organs

  • Urokinase

    Product Urokinase

    1、A kind of zymoprotein extracted from human urine

    2、Activate the endogenous fibrinolysis system and convert plasminogen into plasmin

    3、Favorable ...

  • Sennae Folium Granule

    Product Sennae Folium Granule

    1、A natural botanical drug for the treatment of constipation recommended by the WGO* Guideline

    2、Purge heat, activate stagnation and relax Intestines

    3、An exclusive product with double sales channels of OTC & prescription

     

    *WGO: World Gas...
  • Ainuomiti Tablets (Anti-HIV/AIDS innovative drug)

    Product Ainuomiti Tablets (Anti-HIV/AIDS innovative drug)

    Ainuomiti Tablets 

    (Ainuovirine, Lamivudine and Tenofovir Disoproxil Fumarate Tablets)

     

    The first innovative oral anti-HIV/AIDS single-tablet combination in China, containing key NCE of Ainuovirine. 

Jiangsu Aidea Pharmaceutical Group Co., Ltd. Resources (1)